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Elfects of sex hormones on fluid and solute transport in Madin-Darby
canine kidney cells. Polycystic kidney disease progresses more rapidly in
men than in women. To investigate the basis for this sexual dimorphism,
we exposed Madin-Darby canine kidney (MDCK) cells grown on collagen-
coated cell culture inserts to control media, or to estradiol or testosterone
(1 nM—i jLM). Compared to control and estradiol-treated cells, testoster-
one stimulated fluid secretion in a dose-dependent manner, enhancing
fluid secretion 4.8-fold at 1 n and 19.7-fold at 1 ,ru (0.59 0.18 vs.
0.03 0.01 jd/cm2/hr, P < 0.001). Chloride transport paralleled fluid
secretion. Testosterone increased cellular cyclic AMP levels 3.2-fold at 1
nM and 12.3-fold at 1 sM (81.3 30.7 vs. 6.6 3.3 pmol/mg protein, P <
0.001). GDPPS (500 jsM), an inhibitor of Gs, and 2',3'-dideoxyadenosine(10 1.LM), an inhibitor of the catalytic subunit of adenylate cyclase,
suppressed testosterone-induced fluid and solute secretion. Neither tes-
tosterone nor estradiol had any effect on microsomal Na,K-ATPase
activity, cellular proliferation or cellular total protein content. Our studies
show that testosterone stimulates fluid secretion and solute transport by
MDCK cells by increasing cAMP generation. In vivo, testosterone may
contribute to cyst expansion by enhancing fluid secretion. This observation
may help explain the worse prognosis of polycystic kidney disease ob-
served in men.
Gender influences both the renal and extrarenal manifestations
of autosomal dominant polycystic kidney disease (ADPKD) [1—3].
Observations in experimental animals and in humans suggest that
the progression of renal cystic diseases to end-stage renal failure
is markedly influenced by gender [1—5]. Nearly all studies have
found that the rate at which renal failure progresses in ADPKD is
more rapid in men than in women [1—3]. Sexual dimorphism is
also a feature of renal cystic disease in the HAN:SPRD cy rat, a
model of autosomal dominant renal cystic disease [4]. In this
model, castration ameliorates and administration of exogenous
testosterone accelerates the course of renal disease, whereas
ovariectomy has no effect [5]. Sex hormones may directly influ-
ence many of the cellular processes implicated in the development
of renal cystic disease including cellular proliferation, matrix
accumulation and fluid secretion [6—8]. The present study focused
on the effects of sex hormones on fluid secretion by Madin-Darby
canine kidney (MDCK) cells grown on collagen-coated cell cul-
ture inserts. This system represents a model of fluid secretion by
cystic renal epithelia [9].
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Renal volume in ADPKD, which reflects the number and size
of renal parenchymal cysts, is correlated with the rapidity of renal
functional deterioration [2]. In this context, renal volume is
greater in normotensive men than in normotensive women with
ADPKD, which parallels the faster rate of progression to end-
stage renal failure in men [1—3, 10]. It has been proposed that fluid
secretion by renal cysts may be driven by cAMP-stimulated
chloride transport, which in turn is dependent on the sodium
gradient established by Na,K-ATPase [9, 11—15]. Since testoster-
one has been shown to stimulate cAMP generation and to
enhance Na,K-ATPase activity in numerous cell types [16—22], we
tested the hypothesis that sexual dimorphism in ADPKD is
related to the ability of testosterone to enhance cyst expansion by
stimulating fluid secretion via increased cAMP generation and/or
Na,K-ATPase activity. Our studies show that testosterone stimu-
lates fluid secretion and solute transport by MDCK cells by
increasing cAMP generation. Thus, testosterone may contribute
to cyst expansion in ADPKD by enhancing fluid secretion. This
observation may help explain the worse prognosis of polycystic
kidney disease observed in men.
Methods
Measurement of fluid secretion by MDCK monolayers
Fluid secretory rate was assessed by measuring the quantity of
fluid that accumulated beneath a layer of mineral oil overlying the
apical surface of a MDCK cell monolayer [9, 23]. Wild-type
MDCK cells (CCL 34; American Type Culture Collection, Rock-
yule, MD, USA) were grown in plastic flasks in DMEM/Ham's
F12 (1:1, vol:vol) media supplemented with 10 mvi HEPES, 40 mM
NaHCO3, 100 units/mI penicillin G and 5% FBS. Cells were
incubated at 37°C in 5% CO2/air. Cell culture inserts (Becton
Dickinson, Franklin Lakes, NJ, USA) coated with type I collagen
(rat tail; Sigma Chemical Co., St. Louis, MO, USA) were seeded
with I x 106 MDCK cells on their upper surface. After six days,
media on the upper surface of the inserts was replaced with 1.5 ml
hydrated mineral oil; 1.5 cc of media remained in the outer
chamber. Three groups of cells were studied in defined media: (a)
control media containing ethanol vehicle, (b) media supple-
mented with estradiol (1 nM—i fLM) and (c) media supplemented
with testosterone (T) (1 nM—I /LM). Fluid and oil on the upper
surface were aspirated after 48, 72 and 96 hours, and centrifuged
at 2,500 rpm. The quantity of fluid secreted was quantified with a
calibrated glass microcapillary tube (Drummond Scientific Co.,
Broomall, PA, USA). Fluid secretory rate was expressed as
volume per cm2 per hour.
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Measurement of Na,K-ATPase activity
MDCK cells were incubated for 72 hours at 37°C in 5% C02/air
with control media, estradiol-supplemented media (1 nM—i xM),
or T-supplemented media (1 nM—i /LM). Na,K-ATPase activity was
then measured in microsomal fractions [25, 26]. Microsomal
fractions were prepared by scraping cells into 1 ml PBS at 4°C.
The cells were centrifuged at 800 rpm at 4°C and the pellet
resuspended in buffer A (5 mvi Tris-HC1, pH 7.4, 0.25 M sucrose)
with 0.2 mivi MgSO4 at 4°C. The cells were mechanically homog-
enized and centrifuged at 3,000 rpm for five minutes at 4°C. The
homogenization procedure was repeated and the microsomal
pellet resuspended in buffer A. Reactions were performed in
duplicate in the presence and absence of ouabain (2.5 mM).
Microsomal fractions were incubated with 100 mi NaCI, 10 mM
KCI, 2.5 mrvi MgCl2, 1 mi Tris-ATP, 1 mrvi Tris (cyclohexylam-
monium) phosphoenolpyruvate, 30 mivi imidazole-HC1 (pH 7.3),
0.15 mM NADH, 50 xg/ml LDH and 30 xg/ml pyruvate kinase.
ATPase activity was calculated from the rate of change in OD
measured at 340 nm at 37°C and is expressed as fmol NADH
oxidized/gram protein/hour. The difference between activity in the
absence and presence of ouabain represents specific Na,K-
ATPase activity.
Results
Testosterone stimulated fluid secretion by MDCK cell mono-
layers at every concentration tested during the first 48 hours of
exposure (Fig. 1A). At a concentration of 1 nM, testosterone
increased fluid secretion 4.8-fold compared to untreated cells
(0.19 0.08 vs. 0.04 0.02 jxl/cm2/hr, P < 0.05, ANOVA with
Scheffe's correction). At a concentration of 1 j.tM, testosterone
increased fluid secretion 19.7-fold compared to untreated cells
(0.59 0.18 vs. 0.03 0.01 j.tl/cm2/hr, P < 0.001). At a
concentration of I nM, the increase in fluid secretory rate elicited
by testosterone reached 24.1% of the maximum increase elicited
by forskolin (10 sM). At a concentration of 1 jxM, the increase in
fluid secretory rate elicited by testosterone achieved 68.7% of the
maximum increase elicited by forskolin (10 LM).
Chloride and sodium concentrations were not significantly
higher in secreted fluid from control, estradiol-, and testosterone-
treated monolayers than in the basolateral bathing solution
(Table 1). However, transepithelial chloride transport and fluid
secretion rose in parallel (Fig. 2A). At a concentration of 1 flM,
testosterone increased chloride transport 4.3-fold compared to
untreated cells (6.58 0.51 vs. 28.67 5.62 nEq/cm2/hr, P <
1.00
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Fig. 1. Fluid secretion by Madin-Darby canine kidney cells incubated with
control media, estradiol or testosterone. A. Values obtained at 48 hours. B.
Values obtained at 96 hours. Abbreviations are: C, control; E, estradiol; T,
testosterone. *p < 0.05, **P < 0.01, P < 0.001.
Sodium and chloride concentrations were measured in the
collected fluid and in aliquots of media in the outer chamber of
the wells. Chloride transport was calculated by multiplying the
fluid secretory rate by the chloride concentration of the secreted
fluid and was expressed as nEq per cm2 per hour.
Measurements of fluid secretory rate were repeated in the
presence and absence of ouabain (10' Sigma), 2,3 dideoxy-
adenosine (DDA), an inhibitor of the catalytic subunit of adenyl-
ate cyclase (I0— Sigma), or guanosine 5'-O-(2-thiodiphos-
phate) (GDPpS), an inhibitor of Gs (500 /LM; Boehringer
Mannheim, Mannheim, Germany). All agents were added to the
outer chamber of the wells.
We also assessed the effects of estradiol and testosterone on
cellular proliferation and total protein content in cultured MDCK
cells. Cellular proliferation was measured by 3H thymidine incor-
poration by techniques previously described in detail by our
laboratory [6]. Cellular protein was measured by colorimetric
assay (Bio-Rad Protein Assay, Richmond, CA, USA).
Measurement of cellular cAMP
To measure cellular cAMP levels, MDCK cells were incubated
for 72 hours at 37°C in 5% C02/air with control media, estradiol-
supplemented media (1 nM, I jiM), or T-supplemented media (1
nM, 1 jiM). The cells were pelleted by eentrifugation and cAMP
extracted with 80% methanol [241. After evaporation to dryness,
0.4 ml of 0.05 M sodium acetate, pH 6.2 was added. cAMP was
measured with a radioimmunoassay kit (New England Nuclear,
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Fig. 2. Chloride transport by Madin-Darby canine kidney cells incubated
with control media, estradiol or testosterone. A. Values obtained at 48 hours.
B. Values obtained at 96 hours. Abbreviations are: C, control; E, estradiol;
T, testosterone. < 0.05, < 0.01, P < 0.001.
0.05). At a concentration of I /.LM, testosterone increased chloride
transport 22-fold compared to untreated cells (5.19 0.10 vs.
114.22 51.04 nEqlcm2lhr, P < 0.001). Sodium transport paral-
leled chloride transport (data not shown).
Fluid secretion and chloride transport were lower in all three
experimental groups at 72 and 96 hours compared to the values
obtained at 48 hours. Nevertheless, the stimulatory effects of
testosterone on fluid secretion and chloride transport were sus-
tained (Figs. lB and 2B). Estradiol had no significant effect on
fluid secretion or chloride and sodium transport at any concen-
tration or time period studied (Figs. 1 and 2).
The stimulatory effects of forskolin and testosterone on fluid
secretion by MDCK cells were not additive [forskolin (10 !LM)
0.85 0.20 jxl/cm2/hr; testosterone (1 .LM) 0.56 0.22 xl/cm3/hr;
forskolin + testosterone 0.93 0.26 jxl/cm2/hr, P = NS]. The
inhibitor profiles of forskolin and testosterone are shown in
Figure 3. DDA reversed the increase in fluid secretion elicited by
forskolin (0.07 0.01 vs. 0.85 0.20 p.l/cm2/hr, P < 0.001) and by
testosterone (0.04 0.01 vs. 0.56 0.22 xl/cm3/hr, P < 0.00 1).
GDPI3S was less effective in suppressing the increase in fluid
secretion elicited by forskolin (0.40 0.02 vs. 0.85 0.20
j.d!cm3/hr, P < 0.05) and by testosterone (0.23 0.01 vs. 0.56
0.22 ixl/cm3/hr, P < 0.05). Ouabain completely reversed forskolin-
stimulated and testosterone-stimulated fluid secretion (Fig. 3).
Testosterone increased cellular cyclic AMP levels 3.2-fold at a
testosterone concentration of 1 nM (25.31 8.02 vs. 8.02 4.03
pmol!mg protein, P < 0.05) and 12.3-fold at a testosterone
concentration of 1 /xM (81.34 30.73 vs. 6.61 3.32 pmol/mg,
P < 0.001). Microsomal membrane Na,K-ATPase activity was
unaffected by exposure to sex hormones at concentrations ranging
from 1 nM—i M (Fig. 4). Neither estradiol nor testosterone had
any effect on cellular protein content or on cellular proliferation
in MDCK cells (Fig. 5).
Discussion
Gender influences both the renal and extrarenal manifestations
of autosomal dominant polycystic kidney disease [1—3]. Nearly all
studies have found that the rate at which renal failure progresses
is more rapid in affected men than in women [1—3]. The Modifi-
cation of Diet in Renal Disease study recently showed that in
patients with ADPKD and a GFR above 25 mi/mm, women had a
slower rate of decline in renal function than did men [3].
Accordingly, men require maintenance hemodialysis on average
5.5 years earlier than do women [1]. Although the prevalence of
hypertension is greater in affected men, male gender and hyper-
tension each independently contribute to the more aggressive
renal course observed in men with ADPKD [2].
Sexual dimorphism is also a feature of renal cystic disease in the
HAN:SPRD cy rat [4, 5]. Heterozygous males develop renal cysts
and progressive azotemia leading to death in uremia at approxi-
mately six months of age [5]. In contrast, severe azotemia is absent
and renal cystic transformation is more slowly progressive in
female heterozygotes [4]. Castration reduces renal enlargement
and the degree of cystic changes in male heterozygotes while
exogenous testosterone is renotropic and worsens BUN in female
heterozygotes [5]. In contrast, ovariectomy was found to have no
effect on the course of renal disease [5].
Gender may also influence the development of acquired renal
cystic disease in patients with end-stage renal disease [27, 28].
Although not a universal observation, most studies have demon-
strated a preponderance of males with this disorder [28]. Renal
cyst size and the extent of cyst formation is nearly twice as great
in men on hemodialysis compared to women, despite a similar
duration of end-stage renal disease [27]. Despite reduced circu-
lating levels of testosterone in men with end-stage renal failure,
testosterone may play a role in stimulating cystic transformation
in patients with acquired renal cystic disease.
The C57BL/6J cpk:cpk murine model of autosomal recessive
renal cystic disease does not show sexual dimorphism [29].
Homozygous cpk mice rapidly progress to uremia over several
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Fig. 3. Fluid secretion by Madin-Darby canine kidney cells incubated with
the agents indicated. Abbreviations are: DDA, 2,3 dideoxyadenosine;
GDPpS, guanosine 5'-O-(2-thiodiphosphate); Ouab, ouabain. *JJ < 0.05,
P < 0.001.
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weeks [291. In contrast, renal disease in heterozygous Han:SPRD
cy rats progresses more slowly and does not lead to uremia in
males until six months of age [4, 5]. The genetically programmed
aggressive course of the renal cystic enlargement in cpk mice may
overshadow any effects of testosterone on disease progression and
explain the failure of gender to influence the course. DBA/2F0
pcy.pcy mice develop a slowly progressive form of autosomal
recessive renal cystic disease. Female pcy mice develop uremia
and die sooner than males despite a similar rate of renal enlarge-
ment [301. The adverse effect of female gender in pcy mice
contrasts with the ameliorative effect of female gender observed in
most experimental models of progressive renal injury [8] and may
reflect inherited sex-linked factors unique to this model.
In various in vitro models of renal cystic epithelia, cyclic AMP
agonists play an integral role in the induction and/or enlargement
of renal cysts [11, 13—15]. Although MDCK cysts absorb fluid in
the absence of secretagogues, they secrete chloride-rich fluid in
response to cAMP [14]. Tn MDCK cells grown in collagen gel
matrix, cAMP agonists stimulate fluid secretion and promote cyst
formation [ii]. cAMP-stimulated fluid secretion by MDCK
monolayers is suppressed by inhibitors of the apical chloride
channel and by inhibitors of basolateral Na,K-2C1 cotransport [11,
15]. On the basis of these observations, it has been suggested that
fluid secretion in cystic epithelia may be driven by cAMP-
stimulated chloride transport [15]. In this context, testosterone
has been shown to stimulate adenylate cyclase activity in all cell
types and tissues studied to date, including adipose tissue, hip-
pocampal slices, striatal neurons and rat hepatocytes [16—19]. In
rat adipose tissue, testosterone increases adenylate cyclase activity
by activating the catalytic subunit [18]. In hamster epididymal
adipose tissue, testosterone increases adenylate cyclase activity via
increased Gs density as well as via direct stimulatory effects on the
catalytic subunit [16].
Na,K-ATPase has also been shown to play an important role in
cyst formation [14, 25, 31—33]. In this context, testosterone has
been shown to stimulate Na,K-ATPase in numerous tissues and
cell types [20—22]. Na,K-ATPase activity is increased in testoster-
one-treated cultured brain astrocytes and in tissue isolated from
the liver or from the hypothalamic and preoptic regions of the
brain of male rats [20—22].
Renal volume in ADPKD, which reflects the number and size
of renal parenchymal cysts, is correlated with the rapidity of renal
functional deterioration [2]. Renal volume is greater in normo-
ten sive men than in normotensive women with ADPKD (390 43
vs. 338 24 cm3, statistical comparison not reported), which
parallels the faster rate of progression to end-stage renal failure in
men [1—3, 10]. Sex hormones may influence renal cyst volume by
modulating fluid secretion by cystic epithelia. Since testosterone
has been shown to stimulate cAMP generation and Na,K-ATPase
activity in numerous cell types, we tested the hypothesis that
sexual dimorphism in ADPKD is due in part to the ability of
testosterone to stimulate fluid secretion by cystic epithelia and
that this stimulatory effect is mediated by enhanced cAMP
generation and/or Na, K-ATPase activity.
Our studies demonstrate that testosterone stimulates fluid
secretion and solute transport by MDCK cells by increasing
cAMP generation. We failed to find any effect of sex hormones on
microsomal Na,K-ATPase activity. Our inhibitor studies suggest
that testosterone increases cellular cAMP levels by directly stim-
ulating the catalytic subunit of adenylate cyclase and via activation
of Gs. Forskolin stimulates cAMP production in two ways: by
directly activating the catalytic subunit of adenylate cyclase and by
activating Gs [34, 35]. Approximately one third of the ability of
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Fig. 5. Proliferation of Madin-Darby canine kidney cells incubated with
estradiol or testosterone espressed as a percent of untreated, control cells.
Abbreviations are: E, estradiol; T, testosterone.
Sandhu et a!: Sex hormones and fluid secretion in MDCK cells 1539
forskolin to stimulate cAMP production is mediated via activation
of Gs [34, 35]. These conclusions are consistent with our obser-
vation that DDA, an inhibitor of the catalytic subunit of adenylate
cyclase, almost completely reverses forskolin-stimulated fluid
secretion whereas GDPJ3S, an inhibitor of Gs activation, causes
only a partial reversal. An identical inhibitor profile was observed
with testosterone. Moreover, the effects of forskolin and testos-
terone were not additive. These data suggest that forskolin and
testosterone increase cAMP by similar mechanisms involving both
direct stimulation of the catalytic subunit of adenylate cyclase as
well as activation of Gs. Basolateral ouabain also reversed testos-
terone-stimulated solute transport and fluid secretion. These
observations are consistent with the conclusion that testosterone-
stimulated fluid secretion by MDCK cells is driven by cAMP-
stimulated chloride transport which in turn is dependent on the
sodium gradient established by Na,K-ATPase.
Our data suggest that in ADPKD, testosterone may contribute
to cyst expansion by enhancing fluid secretion. This observation
may help explain the worse prognosis of polycystic kidney disease
observed in men.
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